Preventing blindness by
improving retinal therapy
AI tools to empower ophthalmologists
Our Vision
Preventing blindness by improving retinal therapy
deepeye empowers ophthalmologists to provide individual therapy to patients suffering from retinal eye diseases like Age-related Macular Degeneration (AMD) and others with a prevalence of >12% in the European and US population, thus preventing the causes of more than 90% of blindness‘.
Our Approach
Treatment of retinal diseases is complex, costly and hardly allows individual treatment of patients.
By developing AI tools for ophthalmology, we plan to significantly improve the therapy process for patients and doctors.
This enables individualized patient care and even more successful therapy outcomes.
Our Solution
The digital therapy assistant
deepeye develops therapy decision support systems for ophthalmologists. Based on high quality retinal images (OCTs), our deep learning models provide a 2nd opinion on the current therapy need and future appointments.
We have been awarded
Winner of the German
AI Award 2020
In 2020, the DeepEye project received the German AI Application Award, an award by WELT for outstanding achievements in the practical application of AI. This pushed us to found deepeye Medical to go through clinical evaluation and then bring this solution to market.
Winner 2nd place
Health-i Award 2021
At the Health-i Award from Techniker Krankenkasse and Handelsblatt, we took 2nd place for our AI-powered therapy assistant for ophthalmologists. We thus were able to prevail among 200 ideas and companies. Many thanks for the great feedback from the jury and other participants!
supported by
Contact us